Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview.

作者: Ferenc Pakodi , Omar M.E Abdel-Salam , Andras Debreceni , Gyula Mózsik

DOI: 10.1016/S0928-4257(00)00160-1

关键词: Internal medicineGastroenterologyGastric mucosaOmeprazoleMALT lymphomaHelicobacter pyloriChronic gastritisStomachGastritisMedicineClarithromycin

摘要: Since the historical rediscovery of gastric spiral Helicobacter pylori in mucosa patients with chronic gastritis by Warren and Marshall 1983, peptic ulcer disease has been largely viewed as being infectious aetiology. Indeed, there is a strong association between presence H. active histology. The bacterium can be isolated not less than 70% over 90% duodenal patients. Eradication organism associated histologic improvement gastritis, lower relapse rate risk bleeding from ulcer. possesses several virulence factors enabling it to survive acid milieu inside stomach possibly damaging host tissues. sequence events which might cause or still fully elucidated Koch's postulates have never fulfilled. In majority individuals, infection entirely asymptomatic no convincing data suggest an increase prevalence among these subjects. An increasingly growing body literature suggests colonization for developing mucosa-associated lymphoid tissue (MALT), MALT lymphoma, adenocarcinoma even pancreatic adenocarcinoma. implicated also number extra-gastrointestinal disorders such ischaemic heart disease, cerebrovascular atherosclerosis, skin diseases rosacea, but causal role missing. thus seems beneficial impact on human health. Various drug regimens are use eradicate involving administration three four drugs including bismuth compounds, metronidazole, clarithromycin, tetracyclines, amoxycillin, ranitidine, omeprazole 1-2 weeks. financial burden, side effects emergence resistant strains due antibiotics eradication therapy need further reconsideration.

参考文章(195)
Korsten Ma, Lieber Cs, Gottfried Eb, Alcohol-induced gastric and duodenal lesions in man. The American Journal of Gastroenterology. ,vol. 70, pp. 587- ,(1978)
Erik A.J. Rauws, Wies Langenberg, Guido N.J. Tytgat, Hendrik J. Houthoff, H.C. Zanen, Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. ,vol. 94, pp. 33- 40 ,(1988) , 10.5555/URI:PII:0016508588906063
McGregor D, Dixon A, Weston Ap, Cherian R, Lawrinenko, Horvat Rt, Mucosa-associated lymphoid tissue (MALT) in Barrett's esophagus: prospective evaluation and association with gastric MALT, MALT lymphoma, and Helicobacter pylori. The American Journal of Gastroenterology. ,vol. 92, pp. 800- 804 ,(1997)
Belinda M. Haile, John H. Kurata, Epidemiology of peptic ulcer disease. Clinics in gastroenterology. ,vol. 13, pp. 289- 307 ,(1984) , 10.1016/S0300-5089(21)00614-3
S. L. Hazell, H. pylori in developing countries Springer, Dordrecht. pp. 85- 94 ,(1994) , 10.1007/978-94-011-1418-9_6
Maria Perez-Paramo, Agustin Albillos, Jose Luis Calleja, Clara Salas, Maria Del Carmen Marin, Maria Luisa Marcos, Guillermo Cacho, Pedro Escartin, Jose Ortiz-Berrocal, Changes in Gastrin and Serum Pepsinogens in Monitoring of Helicobacter pylori Response to Therapy Digestive Diseases and Sciences. ,vol. 42, pp. 1734- 1740 ,(1997) , 10.1023/A:1018873717985
B. J. Marshall, Epidemiology of H. pylori in Western countries Springer, Dordrecht. pp. 75- 84 ,(1994) , 10.1007/978-94-011-1418-9_5
N Ikemura, I Imoto, S Takaji, Y Taguchi, K Yamauchi, T Shibata, K Nakao, M Misaki, N Yamazaki, Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. The American Journal of Gastroenterology. ,vol. 92, pp. 1005- 1011 ,(1997)
G.N.J. Tytgat, L.A. Noach, E.A.J. Rauws, HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE Gastroenterology Clinics of North America. ,vol. 22, pp. 127- 139 ,(1993) , 10.1016/S0889-8553(21)00268-5